glp-1 physiology informs the pharmacotherapy of obesity Multifaceted Nature GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases Metabolic Flux Adaptations During GLP-1

Pharmacokinetic Interaction Deep Dive UGT1A9 and Why It Matters Dapagliflozin's primary metabolic pathway is glucuronidation by UGT1A9, which produces the inactive metabolite dapagliflozin-3-O-glucuronide

Nutrition plays a key role in supporting both weight loss and long-term maintenance

Eat smaller frequent meals, avoid high-fat foods, stay well-hydrated, and follow the prescribed dose-escalation schedule

Low levels of glutathione are associated in those with neurodegenerative diseases

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Inflammatory Bowel Disease: Mechanisms, Clinical Implications, and Therapeutic Potential